Lipoprotein-associated phospholipase A(2) activity and mass in relation to vascular disease and nonvascular mortality

Geahča maid

• Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality.
  Dahkki: Heart Protection Study Collaborative Group
  Almmustuhtton: (2010)
• Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
  Dahkki: Erqou, S, et al.
  Almmustuhtton: (2009)
• The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
  Dahkki: Kent, S, et al.
  Almmustuhtton: (2016)
• Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
  Dahkki: Thompson, A, et al.
  Almmustuhtton: (2010)
• Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.
  Dahkki: Parish, S, et al.
  Almmustuhtton: (2012)